GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (XCNQ:RVV) » Definitions » Payments of Debt

Revive Therapeutics (XCNQ:RVV) Payments of Debt : C$-0.18 Mil (TTM As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Revive Therapeutics Payments of Debt?

Revive Therapeutics's Payments of Debt for the three months ended in Sep. 2024 was C$-0.03 Mil.

Revive Therapeutics's Payments of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was C$-0.18 Mil.

Revive Therapeutics Payments of Debt Historical Data

The historical data trend for Revive Therapeutics's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revive Therapeutics Payments of Debt Chart

Revive Therapeutics Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.14 -0.15 -0.15 -0.15 -0.20

Revive Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.04 -0.04 -0.08 -0.03

Revive Therapeutics Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revive Therapeutics Payments of Debt Related Terms

Thank you for viewing the detailed overview of Revive Therapeutics's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Revive Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (XCNQ:RVV) » Definitions » Payments of Debt
Comparable Companies
TSX:WLLW XCNQ:SLNG TSXV:NDVA XCNQ:IMCC TSX:CTX XCNQ:STHZ XCNQ:OILS XCNQ:XTRX TSX:VPH XCNQ:CANN ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
RVVTF:USA 31R:Germany
Address
82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C 1P1
Website
https://www.revivethera.com
Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care. Currently, the Company is exploring the use of Bucillamine for the potential treatment of public health medical emergencies and rare inflammatory disorders. Revive is also advancing the development of Psilocybin-based therapeutics through various program.
Executives
Michael Frank Director, Senior Officer
Derrick Alexander Welsh Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)

Revive Therapeutics Headlines

No Headlines